About
Basic Data Updated:
2 months agoThe Corporate was formerly known as Meditab Specialities Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 cr and a paid-up capital of Rs 0.71 cr, as per the Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Meditab Specialities Limited India are Girish Zamwar as Cfo and Pavan Yadav as Company Secretary. Dinesh Jain, Anisha Udeshi, and Sanjay Mishra serve as directors at the Company.
Industry
Company Details
- Location
Thane, Maharashtra, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
CIN/LLPIN/FCRN | U23240MH1996PLC104442 |
Company No. | 104442 |
Company Classification | Public Limited Indian Non-Government Company |
Incorporation Date | 11 Dec 1996 |
Date of AGM | 29 Sep 2023 |
Date of Balance Sheet | 31 Mar 2023 |
Listing Status | Unlisted |
ROC Code | Roc Mumbai |
Financials of Meditab Specialities Limited
Meditab Specialities Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13924.66% increase. The company also saw a substantial improvement in profitability, with a 4881.91% increase in profit. The company's net worth moved up by a moderate rise of 1.87%.
Corporate Structure
Unlock access to Meditab Specialities's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Meditab Specialities Limited
Unlock and access historical data on people associated with Meditab Specialities, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
SM
Sanjay Mishra Managing DirectorAppointment Date: 21-Oct-2022
Status: Current
GZ
Girish Zamwar CFOAppointment Date: 05-Mar-2020
Status: Current
PY
Pavan Yadav Company SecretaryAppointment Date: 28-Aug-2023
Status: Current
Board Members(2)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditab Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditab Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Medispray Laboratories Private Limited
Active 32 years 6 monthsDinesh Jain, Anisha Udeshi and 1 more are mutual person
Cipla Pharmaceuticals Limited
Active 4 years 10 monthsDinesh Jain and Anisha Udeshi are mutual person
Recent activity within the organization
Annual General Meeting
Meditab Specialities Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Director Appointment
Pavan Kumar Kadedin Yadav was appointed as a Company Secretary was appointed as a Company Secretary on 28 Aug 2023 & has been associated with this company since 1 year 23 days .
28 Aug 2023Balance Sheet
Meditab Specialities Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Director Appointment
Sanjay Kumar Mishra was appointed as a Managing Director was appointed as a Managing Director on 21 Oct 2022 & has been associated with this company since 1 year 11 months .
21 Oct 2022Director Appointment
Anisha Naresh Udeshi was appointed as a Director was appointed as a Director on 23 Aug 2021 & has been associated with this company since 3 years 28 days .
23 Aug 2021
Recent News, Updates & Announcement
- Cipla Raises Stake In Digital Tech Startup GoApptiv To 2299 For INR 42 Cr.
StartupNews 02 Feb 2024
- Cipla aims to grow respiratory leadership in the US files Symbicort and another generic inhaler.
The New Indian Express 29 Jan 2024
- Cipla Q3 FY24 Results Live Profit Rises by 3183 YoY Mint.
Cipla Q3 FY24 Results Live Revenue Increased by 1366 YoY Profit Increased by 3183 YoY.
mint 25 Jan 2024
- Ciplas EU arm Kemwell Biopharma to establish JV company in USA.
Moneycontrol 06 Jan 2024
- Cipla to sell Croatian subsidiary to PharmaS.
VCCircle 01 Dec 2017
Frequently asked questions
What is the Incorporation or founding date of Meditab Specialities Limited?